An extract from tomato seeds has been detected to be a possible substitute to aspirin in thwarting coronary failures as well as strokes.

The tomato derivative called Fruitflow, which is derived from the gelatine that borders tomato seeds, is apparently effectual in lessening the risk of blood coagulation.

Researchers at Aberdeen's Rowett Institute stated that the outcomes of the latest examinations were statistically important.

Provexis, a spin-off company of the research institute, which makes Fruitflow, has published its findings after equating the effects of Fruitflow and aspirin for seven-month period utilizing 43 individuals.

Chief executive Stephen Moon said, "We are delighted with the results of this latest human trial, which highlights the substantial effect that Fruitflow can have, without the associated side effects known to occur with aspirin."

"We have already announced intent to enter into an agreement with DSM Nutritional Products, the world''s leading supplier of vitamins, carotenoids and other fine chemicals to feed, food, pharmaceutical and personal care industries," he added.

No ill effects were found even when Fruitflow and aspirin were taken simultaneously.

The disadvantages of aspirin include: it raises chance of ulcers and stomach bleeding. (With Input from Agencies)